Aim: The purpose of our study was to assess impact of early enteral nutrition (EN) after allogeneic-SCT (allo-SCT) in adult patients with hematological diseases. At our center, no patient received EN before 2012, but since January 2012, we have decided to off er EN from day 1 (d1) of transplant until discharge from hospital. This change prompted us to evaluate the potential consequences of EN on several nutritional parameters and transplant outcome. Method: From Jan 2011 to Dec 2012, 166 allo-SCT were performed, of which 50 with EN for at least 7 days (EN group). Conditioning regimens (CR) were myeloablative (MAC, n=80) or reducedintensity (RIC, n=86). The nasogastric tubing was performed at d1 (d1-d7), the EN was started at d2 (d1-d7) and continued for a median time of 17 days . Patients received 500 kcal/d from d1 to d3, 750 kcal at d4-d5, 1125 kcal at d6, and 1500 kcal from d7. The remaining 116 allo-SCT were performed without EN (NEN group). Transplants with EN < 7 d were not included. Variables considered in analysis of acute (a) GVHD were EN vs NEN, age (<40 vs 40-60 vs > 60 years), MAC vs RIC regimen, antithymocyte globulin (ATG) vs no ATG in the CR, related vs unrelated donor, HLA mismatch vs no mismatch, female donor/male recipient vs other combinations, GVHD prophylaxis with cyclosporine + methotrexate vs others, source of stem cells (peripheral blood vs bone marrow vs cord blood). Results: Both groups (EN and NEN) were comparable concerning diseases and above variables except for ATG in the CR (62% vs 46%, p=0.05). The albumin level was below normal at admission in both groups (34.80 vs 34.65 g/l). It was normal at 1 and 3 months (38.40 vs 38.60 g/l and 40.05 vs 39.90 g/l). The weight loss between admission and 1 month (-2.41% vs -3.49%), between 1 and 3 months (-0.00% vs -1.63%), and between admission and 3 months (-2.78% vs -4.64%) was more limited in EN group. In EN and NEN groups, the 1-year overall survival was 71% ± 7% vs 73% ± 4%, respectively (p=0.6). Rates of overall infections and infections from the digestive tract were comparable in EN and NEN groups (44% vs 53%, p=0.3 and 6% vs 12%, p=0.2; respectively). EN had no impact on median time to neutrophil engraftment to 0.5 x 10 9 /L (17d vs 17d, p=0.8), or platelet engraftment to 20 x 10 9 /L (7d vs 9d, p=0.2). In univariate analysis, cumulative incidence of aGVHD II-IV in EN and NEN groups was 26% ± 6% vs 46% ± 4% (p=0.016). In multivariate analysis, variables associated with a reduced risk of aGVHD II-IV were EN (HR=0.5, p=0.02), RIC regimen (HR=0.6, p=0.03), and related donor (HR=0.4, p=0.0009). Conclusion: We conclude that early EN helps maintaining an adequate nutritional status after RIC or MAC allo-SCT by limiting weight loss. Our study also suggests that early EN is associated with an interesting reduced morbidity by limiting the risk of aGVHD II-IV. Disclosure of Interest: None Declared. Aim: Haematopoietic stem cell transplant patients receiving intensive conditioning regimens that manifest mucositis and gastrointestinal toxicities, are at risk of malnutrition during and after transplantation 1 . Malnutrition and weight loss have been adversely linked with prognosis, increased infections and reduced survival 2 . Optimal nutrition support therefore becomes essential early in the course of treatment 3 . The Malnutrition Universal Screening Tool 'MUST' is eff ective at identifying malnutrition risk amongst universal hospital inpatients 4 . National nutrition support guidance advises that outpatients should also be screened at initial visit and upon clinical concern 5 . To promote a multidisciplinary approach to monitoring nutritional risk throughout the patient's transplant journey, an individualised nutritional screening care pathway using 'MUST' was developed for Bristol Bone Marrow Transplant Unit. Method: Each patient is screened and a low, moderate or high risk care plan is implemented. All patients identifi ed as high risk (including all patients receiving high intensity conditioning) are advised nasogastric tube placement on the day of transplantation and referred to the Dietitian. An outpatient nutrition screening pathway was also adapted from one in use at Bristol Oncology Centre. All outpatients are screened at initial visit and weekly up to 100 days post-transplant. Patients are screened thereafter upon clinical concern in clinic. Results: A nutrition education board was designed to raise awareness of the importance of nutritional screening amongst medical and nursing staff , in conjunction with an education programme incorporating patient case studies. Nutrition advice sheets were developed for nursing staff to off er oral nutrition support advice for low to moderate risk patients. Dietary advice booklets for symptom management were also made available on the units. Conclusion: Nutritional screening using 'MUST' can be implemented in a specialist HSCT inpatient and outpatient unit to allow optimal monitoring and transition of nutritional care for patients during and after transplantation. Treatment-specifi c nutrition care pathways can help staff to pre-empt conditioning side-eff ects that may aff ect a patient's ability to maintain their nutritional status and intervene early on. Dietetic and nursing resources can be directed towards patients with the highest risk of malnutrition. Disclosure of Interest: None Declared.
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expert nursing intervention and involvement from the extended multi-disciplinary team. On discharge patients can feel vulnerable and frightened returning to their home environment to continue their complex treatment regimes. Aim -All patients to receive a senior nurse telephone follow up call within 7 days of discharge -Ensure patients have the name/number of their key workers (Cancer Nurse Specialist) -Ensure they have the contact number for the wards 24hour helpline -Patients aware of follow up appointment -Patient feedback on inpatient stay -Concerns regarding health, medications and well being since discharge explored Method: -Ward clerk collects data of inpatient discharges -Senior nurse contacts patients within 7 days of discharge to collect feedback and give advice regarding any concerns -Data is collated and inputted into an electronic proforma -Areas of concern are addressed immediately Results: Since implementation in April 2013 till present, October 2013, 165 patients were contacted; of those 135 were able to give feedback and 30 were uncontactable, therefore messages were left. Feedback highlighted; -88% had the contact details of their contact workers -All patients had ward 24 hour helpline number -90% felt they had been given enough information and did not require further information at present time -87% of patients contacted felt they had enough support on discharge and were aware of how to access further help and support -60% of patients expressed concerns regarding the quality of food -100% of patients were followed up within 7 days of discharge Positive patient feedback has been received to date with regards to improving the patients journey. Data is currently being collated to evaluate the eff ectiveness of this service which will be refl ected locally and in the National Cancer Patient Survey 2014.
Conclusion: The telephone follow up service has been successfully implemented, positive feedback has been received from both patients and their signifi cant others. Discharge from hospital after intensive treatment can be a very daunting and stressful experience for our patients, having a service that allows ongoing contact with the professional team who have been directly involved in their care has reduced their worries and fears and enabled clarifi cation of medication/treatment queries. The service has also highlighted areas that could improve patient satisfaction during their stay, one of the key areas identifi ed is nutrition. The nursing team has been able to take a pro-active approach, a steering group has been formed and a service improvement project is currently underway. Disclosure of Interest: None Declared. Aim: Herpes zoster infection is caused by the varicella zoster virus and is a common complication following hematopoietic stem cell transplantation. Herpes Zoster infection represents a reactivation of latent varicella zoster virus and usually presents as a localized skin eruption, which may be treated with oral or intravenous antiviral therapies and often requires admission to hospital. There is signifi cant morbidity from post-herpetic neuralgia, and pain and discomfort may be present for long periods following the disappearance of the skin lesions. Infrequently, Herpes Zoster infection is complicated by disseminated cutaneous involvement or visceral organ involvement.
NP004 HERPES ZOSTER INFECTION IN THE POST HAEMAPOETIC STEM CELL TRANSPLANT PAEDIATRIC POPULATION: A SINGLE CENTRE EXPERIENCE
Our aim was to look at the incidence of reactivation in our centres paediatric Haemopoetic Stem Cell Transplant population and to try and identify the high risk factors that may lead to an increased risk of reactivitation. Moreover, looking whether pre-transplant varicella zoster virus seropositivity in recipients is a signifi cant risk factor indicator for post-transplant Herpes Zoster infection. Thereby leading on to further research and a possible change in our current practice. Method: We conducted a retrospective study assessing all patients who under-went Allogenic and Autologus haemopoetic stem cell transplant at Crumlin Childrens Hospital (Ireland) over a 2 year period. We looked at patient's diagnosis, conditioning regimen, seropositivity, immunoprophylaxis and graft-versus-host disease therapy. In addition we looked at duration of aciclovir prophylaxis, incidence of reactivation, severity of zoster infection and the length of time out from transplant the reactivation of the herpes zoster occurred. The diagnosis of Herpes Zoster was diagnosed clinically and all patients received either oral or intravenous aciclovir.
Results: Our fi ndings identifi ed that the paediatric haemopetic stem cell transplant population are at high risk of contacting herpes zoster infection following transplant. Despite our numbers being small there are many variables identifi ed however it appears that the identifi cation of varicella seropositive patients pre-transplant and the duration of aciclovir prophylaxis are important in the prevention of reactivation. Conclusion: Although this was a single centre experience, given the frequency of reactivation of Herpes Zoster in this immunocompromised high risk group, is there an indication for screening for Varicella Zoster Virus to be incorporated into pre transplant work up and an extension of antiviral prophylaxis in the post transplant period? The adaptation of both of these would lead to a change in our current guidelines and practice. Disclosure of Interest: None Declared. Aim: Background: Virtually all patients receiving intensive conditioning regimens for autologous hematopoietic stem cell transplantation (HSCT) experience pain and variable degrees of oral mucositis which may impair the intake of food or fl uids, as well as the administration of medications per mouth. High dose chemotherapy with alkylating agents, such as melphalan, is associated with the highest risk of severe mucositis, and the mucosal barrier damage may extend to the entire digestive tract causing painful swallowing, abdominal pain and diarrhea, with need of systemic analgesia and parenteral nutrition. Topical analgesia by oral rinses with diff erent solutions can provide signifi cant pain relief for oral mucositis, delay the need of systemic analgesia and parenteral nutrition and contribute to improve the comfort of patients during the admission in the transplantation facility. Objectives: We aimed to assess the eff ect of mouthwashes with an ionic solution supersaturated with calcium phosphate (Caphosol™), compared with lidocaine 1‰ viscous solution, in the pain caused by the oral mucositis induced with high dose melphalan in patients undergoing autologous HSCT. Method: Patients and methods: We evaluated 51 consecutive adult patients with lymphoid malignancies conditioned with one of three diff erent regimens: BEAM (BCNU, etoposide, cytarabine, melphalan); BuMel (busulfan, melphalan); or MEL200 (melphalan). They were treated with 15 ml Caphosol™ rinses, every 6 hours Aim: Background Oral mucositis (OM) is a toxic infl ammatory reaction of the mucous membrane in the mouth where oedema, ulceration and/or pain can occur. The ulcers increase the chance of bleeds and systemic infections, especially in patients with a compromised immune system (Dutch guideline OM 2007) . The majority of multiple myeloma (MM) patients who receive high dose mephalan (HDM) as conditioning for an autologous stem cell transplant suff er OM as a result (Lilleby 2006) . Cryotherapy, in which the area around the mouth where the HDM is administered is cooled by the patient sucking on wafers of ice, could reduce the severity and duration of OM caused by HDM. The most common hypothesis to explain this eff ect is found in vasoconstriction caused by the cooling. This could reduce the local delivery of the chemotherapy in the mucous membrane of the mouth. Method: We conducted a literature search in Pubmed and Cochrane into all relevant English articles from 2004 wherein the aff ect of cryotherapy during HDM administration was investigated and described, versus alternative methods. The search terms used where "oral mucositis", Mephalan, "autologous transplantation" and cryotherapy. Data from the randomised studies where the results concerned the eff ect on severity and duration of OM, tolerability of the intervention. The reliability of the results (p-values, nurse training, use of validated measuring tools) and the size of the groups investigated where also considered.
NP005 A COMPARATIVE STUDY OF THE EFFECT OF MOUTHWASHES WITH AN IONIC SOLUTION (CAPHOSOL™) VS. LIDOCAINE 1‰ VISCOUS SOLUTION, ON THE MUCOSITIS ASSOCIATED TO DIFFERENT CONDITIONING REGIMENS IN AUTOLOGOUS

Results:
The literature search resulted in one Randomised Clinical Trial and three useable explorative investigations for answering the study research question. Also four systematic reviews were found and two letters to the editor. Most of the research involved small patient numbers, average N=50 and the same measuring tools were not used in all the studies to determine the severity of OM. In named studies there was a signifi cant diff erence in cryotherapy versus no therapy found, variability from 3-14% grade 2-3 OM with cryotherapy versus 40-86% without cryotherapy.
Conclusion: Cryotherapy is simple for nurses to implement, cost eff ective and easily tolerated by the patients (Vorkurka 2011) . Despite the small size of the investigated cohorts and the fact that the implementation of a larger study is desirable, we recommend the administration of cryotherapy. Disclosure of Interest: None Declared. Aim: Oral mucositis aff ects a high number of cancer patients who are being treated with chemotherapy and radiation therapy. An initial erythema can turn into an ulceration with an increased risk of mucosal infection and infl ammation. Oral mucositis may cause severe pain that can lead to swallowing diffi culties. Therefore it might not just negatively aff ect the entire nutritional intake of the patient, but also the patient's quality of life and comfort. For about a year we have been using a low level laser therapy (LLLT) to prevent or treat cases of incipient or existing mucositis at our bone marrow transplantation ward. Our aim is, to show our experience during the observation period. Method: LLL therapy uses specifi c wavelengths of high energy light without thermic eff ect. It is thought to activate the cell metabolism and supports the reduction of injured and necrotic tissue. By also activating and accelerating wound healing, it promotes the relief of pain and infl ammation. We are using the AreaLaser FL-35000 to prevent or to treat mucositis and initiate laser therapy, when fi rst signs of mucositis appear or the patient complains about pain. Depending on patient age and compliance, the mucositis will be lasered 1 to 2 times per day. The laser is placed directly over cheeks and throat of the injured area for 10 minutes. Patient and nurse have to wear safety glasses during the entire laser session. Case report: 16 year old patient with high risk acute lymphoplastic leukaemia, already suff ered from bloody mucositis WHO°IV after the fi rst high risk courses of chemotherapy with high dose methotrexate (MTX) and with long time of parental nutrition. We decided to use LLL therapy to prevent an extensive muscositis on the second and third course of chemotherapy, and during conditioning regiment of allogeneic bone marrow transplantation. A signifi cant eff ect was seen after the treatment leading to less pain, better wound healing, and a shorter treatment with parenteral nutrition and less use of opioids. Results: After a year of applying laser therapy at our bone marrow and stem cell transplantation ward, we have been noticing a good compliance of the patient and an explicit request of that treatment. The patient appreciates the comfortable and convenient, non-invasive therapy and can notice the pain relief after the fi rst use of the laser treatment. By using LLL therapy as prevention treatment, we observed less mucositis after or during high dose chemotherapy and radiation. Conclusion: LLL therapy is very suitable as an alternative pain treatment, which accelerates the wound healing process and reduces infections. For the nursing staff it is a time consuming treatment, and needs therefore further studies to proof the eff ectiveness of the benefi ts. Disclosure of Interest: None Declared. Vomiting (0-20 days); Nausea (0-22 days) and Mucositis (0-15 days). The B-Thal patient demonstrate: Diarrhoea (0-11 days); Vomiting (0-10 days); Nausea (0-7 days) and Mucositis (0-10 days). The SCA patients with TPN support retrieved the weight loss in days + 41 to +65 post-HSCT, instead the SCA patient with O.N retrieved the weight in days + 21 to +74 post-HSCT. The B-Thal patient with TPN recovered the weight loss in days +21 to 69 post-HSCT and the B-Thal using only O.N recovered the weight loss in days + 11 to +53. Conclusion: Comparing this data appears that patient with B-Thal demonstrating less drugs toxicity in pre and post HSCT, recover more quickly weight loss. In our evaluation should be noted that the B-Thal patient use only O.N recover very fast the weight. Our strategy is to encourage a better oral nutrition and use less TPN for all the HSCT process. Disclosure of Interest: None Declared. Aim: Background -The University of Benin Teaching Hospital has performed three HSCT since the fi rst recorded successful HSCT in September 2011. A proper diet control has been a very important measure towards reducing mortality. Objective -Prevention of malnutrition, control of infection and prevention of gut GVHD with a controlled diet program in a developing country like Nigeria is very necessary. The African diet is quite diff erent from the western diet. It was a big challenge in setting up a standard unit to meet up with Nutritional requirements of HSCT patients. Method: The transplant unit has an inbuilt kitchen to suit the transplant center and to avoid contamination of food. The cooks were screened for communicable diseases and trained on hand washing with soap, to keep prepared food hot, proper boiling of meat, and general safe food handling. We do not keep perishable food such as milk, meat, and sandwiches at room temperature for more than 2hours, avoid all fresh fruits and vegetables including fresh garnishes, avoid dried fruits and nuts, avoid raw milk, fried, naturally aged cheese, cheese with molds and all yoghurt and yoghurt products with live cultures, avoid salad bar and do not purchase perishable foods from street Vendors "coff ee carts". Meal books were used for preparation of patients' food.
NP007 LASER THERAPY -A NEW TREATMENT OPTION ON ORAL MUCOSITIS
NP008 A RETROSPECTIVE STUDY OF NUTRITIONAL ASPECT IN THE PATIENT UNDERGOING HSCT FOR B-THALASSAEMIA AND SICKLE CELL ANAEMIA IN A MULTIETHNIC GROUP. TOTAL PARENTERAL NUTRITION (TPN) VS ORAL NUTRITION
NP009 NURSING CHALLENGES IN DIET CONTROL FOR HEMATOPOLETIC STEM CELL TRANSPLANT (HSCT)PATIENTS
Results: We have successfully managed three pediatric patients in our unit with good control of diet. There was only one reported case of food induced mild gastroenteritis resulting from a patient eating food containing palm oil that wasn't properly cooked. There was no evidence of malnutrition and patients were gradually returned to normal diet after 100 days post HSCT. Conclusion: With improved diet control, the center have gradually designed a protocol to ensure good nutrition and reduce chances of gastroenteritis. Disclosure of Interest: None Declared. Aim: The aim of nutritional intervention (NI) during hospitalization in patients undergoing hematopoietic cell transplantation (HCT) is to maintain the nutritional status and protein reserves. Protein-calorie malnutrition, due to increased metabolic activity, decreased food intake and gastrointestinal symptoms (GIS), contributes to the development of secondary complications to treatment and increases the risk of infection, which may prolong the recovery period post HCT both in autologous and allogeneic. Method: A pre transplant nutritional assessment was performed to all patients during 2012 on the fi rst day of admission by the clinical nutrition unit. The main anthropometric measure was the weight. We also evaluated type of transplant, conditioning, body mass index (BMI) and GIS. Monitoring of the main GIS (nausea, vomiting, diarrhea, xerostomy, and anorexia), fever, weight, oral intake and also mucositis grade was conducted during hospitalization until discharge. NI performed is classifi ed as: nutritional advice and diet adaptation, oral nutritional support (ONS), enteral nutrition (EN) and parenteral nutrition (TPN). Results: From January 2012-December 2012 the NI was evaluated in 66 patients undergoing HCT: 38 auto, 28 allo (12 reduced intensity and 16 myeloablative). Median age 55 (20-69) years, with 58% men. The 24% of the patients had had unintentional weight loss > 5% pre transplant. The median hospital stay was 24 days (3-82) with a period of grade IV neutropenia (<500N) of 9.5 days (0-79) and 92% of the patients presented fever during hospitalization. Mucositis was present in 91% of the patients: I-II grade 59% vs. III-IV 31% according to World Organization Health's oral toxicity scale. Regarding GIS : 63% of patients had vomiting, 53% had nausea grade 0 to 3 vs. 47% grade 4 to 10 according to visual analogue scale (VAS); 46% had diarrhea. The whole group had some degree of anorexia and xerostomy. All patients were given nutritional advice and diet adaptation (low bacterial diet) during the period of neutropenia. In 37 (56%) patients ONS was required; 3 (8%) of which needed TPN and other 3 (8%) EN by nasogastric. ONS employed were hypercaloric and hyperproteic and were calculated according to patient's energy needs with a median of 6 (1-24) days of supplementation. The BMI assessed at discharge increased after NI in 28% of patients and 51% suff ered a decrease in BMI less than 5% with respect to income. Conclusion: The NI in patients admitted undergoing HCT is essential to reduce and complications related to malnutrition. Checking the nutritional impact symptoms that impede intake is essential because the preferred method for NI is the NOS with an adapted diet; it was required in nearly 60% of patients. The NI must be a multidisciplinary goal to achieve a better tolerance of the transplant process and increase the quality of life of HCT patients during hospitalization. Disclosure of Interest: None Declared. Aim: This descriptive study was conducted in order to determine the pain beliefs and aff ecting factors of the cancer patients subjected to hematopoietic stem cell transplantation. Method: The sample of the study was 94 hematologic cancer patients monitored and treated at the Gazi University Research and Application Hospital Stem Cell Transportation Unit. "Pain Beliefs Scale" and 33 questions prepared by the researcher by examining the literature were used as the data collection means. For the analysis of the data, descriptive statistics, Mann Whitney U test, single way variance analysis, t test in independent groups were used. Results: According to the fi ndings of the research, pain severity average of the patients suff ering pain was 4.9±1.9 and the pain severity of women and those using growth factor was high. Organic beliefs score average of the patients under the study was found to be 3.8±0.9 and psychological beliefs score average was found to be 4.7±1.0. In our study, psychological beliefs score average of the patients were found to be higher in all age groups than the organic beliefs score average. The organic belief scores of patients were high in married patients, while psychological beliefs were high in single patients. The pain beliefs were not aff ected by the age, education level, gender, working status, monthly income, diagnosis, pain severity and the region where the patient lived for the longest period (p>0.05). However, the organic beliefs score average of the patients who agreed that cancer could cause pain was signifi cantly high from the statistical point of view (p<0.05). Conclusion: According to the results obtained from the study, nurses were recommended to assess the organic and psychological beliefs with respect to the cause of the pain of the patients suffering pain. Aim: A signifi cant proportion of patients will develop complications requiring admission to an intensive care unit after allogeneic stem cell transplantation (ASCT). Such complications have been considered to convey a poor prognosis with very few patients surviving intensive care treatments such as mechanical ventilation, pressure support and hemodialysis. This poor chance of survival is stressful on the patient and the relatives as well as putting the transplant unit, the intensive care unit (ICU) and the staff , including the nursing staff under considerable strain. These are patients with multi organ failure, requiring large staff and equipment resources. We retrospectively analyzed demographics and survival in patients needing ICU treatment after ASCT in our institution and to try to establish methods to identify patients who might have a better chance of surviving intensive care treatment.
NP010
NP011 PAIN BELIEFS AND AFFECTING FACTORS OF THE HAEMATOLOGICAL CANCER PATIENTS RECEIVED STEM CELL TRANSPLANTATION
Method: Demographics and survival data from patients needing ICU treatment after ASCT were retrospectively analyzed. The patients were identifi ed in the local transplant register and data reviewed through examination of patient fi les. Statistical analyses were performed using the SPSS 20 software package. Survival was analyzed using the Kaplan-Meyer method. Results: The median time from ASCT to ICU transfer was 27,5 days (range -3 -2907). Patient characteristics are shown in table 1 and are based on number of patients (n=99). From 2002 From -2012 patients underwent ASCT in our hospital. 22.6% of these patients developed complications requiring transfer to the ICU. In addition, 11 of these patients required two admissions (110 admissions in total). Aim: This study is an implementation project based on evidence that emphasizes the importance of physical activity and psychoeducation as a complementary intervention in patients with hematologic disease during allogeneic cell transplantation (allo-SCT). The implementation project aims to optimize treatment for patients undergoing allo-SCT by preventing and/or minimizing loss of physical capacity and functional performance and maintaining quality of life. Method: The implementation process is based on the RE-AIM model that integrates a systematic analysis of current practice, identifi cation of factors that impact change in clinical practice, adoption and implementation of a physical activity and psycho-education intervention and evaluation to ensure future sustainability. Patients included are hospitalized for allo-SCT at the Department of Hematology at Copenhagen University Hospital. This ongoing implementation project was initiated May 2013. Results: The preliminary results from the analysis of current practice show that patients are inactive during hospitalization for allo-SCT, nursing practice regarding mobilization is both lacking and inconsistent, and clinical practice is not guided by evidenced based physical activity recommendations. Conclusion: There is an eminent need for systematic implementation of evidence-based physical activity guidelines in clinical practice to reduce treatment-related side-eff ects during allo-SCT and reduce late eff ects and complications. RE-AIM is a relevant and useful implementation framework for planning, designing, carrying out, maintaining and evaluating an intervention in the clinical setting. Disclosure of Interest: None Declared.
[NP013] Aim: Delirium is a serious complication of hematopoietic stemcell transplantation (HSCT), yet only few reports exist about preventive measures, assessment strategies and multi-component-interventions applied on HSCT wards. The aims of this study were: -To develop an evidence-based standard operation procedure (SOP) on prevention and treatment of delirium in HSCT patients -To implement the SOP and an assessment tool for delirium in the multidisciplinary care team -To evaluate team perceptions on the content of the SOP and its value for daily clinical practice. Method: A practice development project on the stem cell transplantation ward of the University Hospital Basel was guided by participatory action research. The project group (5 nurses, one senior physician), led by a Nurse Master student, met 7 times. First, a systematic literature search was performed concerning delirium in the HSCT population. Second, a SWOT-Analysis (Strengths, Weakness, Opportunities, and Threats) of current practice of delirium prevention and treatment was conducted. As a next step the project team selected an assessment tool and devised a recommendation for the medical treatment of delirium. Subsequently a care path for delirious patients was established and lessons for the nursing team were performed. Before and 6 months after the lessons the perceived competence and security feeling (CSF) was rated by nurses' self-report on a numeric rating scale (NRS) (0 ="not at all competent/secure" and 10 ="absolutely competent"). Additional written feedback of nurses in regard to delirium management was analyzed with a content analysis. Based on this initial work the SOP was developed and implemented in daily clinical practice. Four months later the success of the implemented SOP was analyzed by a medical record review (% of patients with implemented care path and % of interventions applied). Results: The SOP and the care path including the modifi ed "Confusion Assessment Method" as screening instrument were successfully implemented. Preventive care measures and medical interventions (Haloperidol and Quetiapin as fi rst line rescue medication) were chosen. Nurses rated their CSF in regard to delirium management before the implementation of the SOP with an average of 4. Aim: Improving outcomes after HT is progressively enlarging the patient population facing unforeseen physical, social and psychological challenges. Whilst their short-term needs are adequately addressed in follow-up clinics, there is a lack of information on the problems arising in long-term survivors. We have prospectively compared the subjective views of a group of long-term (LT; ≥60 months post-HT) survivors with those of short-term survivors (ST; >12 and <60 months) through a previously-validated self-assessment questionnaire. Method: All patients attending our outpatients clinic after more than 12 months of receiving an allograft as consolidation treatment for malignant conditions were presented this study. Patients accepting to participate were asked to sign an informed consent,
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and were provided with the FACT-EBMT Quality of Life Self-Assessment Questionnaire and asked to return it on their following visit. This questionnaire consists of 47 questions covering their physical, familial, social, emotional and functional wellbeing. Patients are asked to answer these questions by scoring them from 0 (never/nothing) to 4 (much/frequently). In addition, patients can also score their overall situation at each of these areas from 0 to 10. Results were fi rst analyzed in a descriptive manner, and then by comparing the scores of ST survivors (33 patients) with those of LT survivors (68). Results: All patients accepted entering this study. Overall, 101 [63 males, 38 females; mean age at HT: 48.4 years (14-69)] patients were included. All patients had received an allograft [myeloablative in 27 cases, non-myeloablative in 74, from related (64 cases) or unrelated (37) donors] at our center between 12 and 172 months (average 56.6) prior to entering this study. Indications for HT were acute leukaemia (34), myelodysplastic/myeloproliferative (27), lymphoproliferative syndromes (30) and multiple myeloma (10). On the whole, 83% patients presented physical tiredness. LT survivors had signifi cantly lower degrees of tiredness (p<0.04) or lack of energy (p<0.02), and specifi c organ complaints were only present in the ST. Functionally, there were no signifi cant diff erences in the proportion of patients returning to work (44.1% ST vs. 49.6% LT). However, LT survivors enjoyed more the working experience (p<0.01). Emotionally, diff erent degrees of sadness were seen in 86.2% patients, still present [although at signifi cantly lower levels (p<0.003)] in the LT. Most importantly, concerns about death were present both in the ST and the LT (overall 57.4% patients) with no signifi cant diff erences found between both groups. Conclusion: Even though functional and physical concerns appear to improve with time, HT patients still present emotional diffi culties after more than 5 years. Our results suggest emotional diffi culties should be sought even in LT HT survivors. Disclosure of Interest: None Declared. Aim: Hospitalization in protected/isolated rooms is frequently adopted in hematological patients undergoing intensive treatment, such as allogeneic (allo) and autologous (auto) stem cell transplantation (SCT), due to a high risk of infections. Prolonged isolation aff ects quality of life, due to both restriction of familiar and social role and lack of psychological relieve of patients; isolation eff ects could be mitigated by adopting communication facilities (internet, TV,etc) and by allowing protected visits (e.g.windows to look inside the room). However, level of evidence of isolation measures effi cacy during SCT is poor, thus resulting in discrepancy between diff erent centers. To compare the strategies of both protection and isolation-eff ects prevention provided to patients undergoing SCT in hospitals of the Rome Transplant Network, a metropolitan network of 6 adult transplant centers in Rome, performing 165 SCT in 2012 (109 autoSCT and 56 alloSCT), with the secondary aim to provide a basis to standardization. Method: Each center fi lled out an assessment form which includes: 1) type of transplantation performed, 2) number of rooms and beds per room (single or multiple beds) 3) type of environmental protection measures, 4) mean hospitalization time in single room, 5) criteria for choice of room type, 6) availability of communication facilities, and 7) ward policy for visitors admission. Results: Forms were delivered and completed on April 2013. Four centers performed autoSCT only, 2 centers both alloSCT and autoSCT. In the centers in which both alloSCT and autoSCT were performed (2), alloSCT patients were admitted in single room and autoSCT in multiple room (positive pressure room, double in 1 and triple in 1) among the 4 centers performing autoSCT only, patients were admitted in single rooms (positive pressure room in 3 and plasma air fi lter room in 1)mean isolation time in single room was 25 days (range 12-40); no centers routinely adopted outpatient management of SCT patients, before hematological recovery. TV and internet access were available in 5/6 and 4/6 centers, respectively. Visitors access was allowed in limited time slots to 1 visitor per time slot only with a median time of 2(2-5) hours, in all centers; access to infants/children was not allowed in any centers; internal windows were present in 3/6 and open spaces in 4/6 centers (access forbidden during aplasia); personal items were allowed in all centers (with the exclusion of books or newspapers in 1 center, only). Conclusion: Our survey showed a moderate level of heterogeneity among centers, with regard of both isolation measures and prevention of isolation eff ects. Moreover, some broadly adopted measures, such as the limitation in time of visit, the prohibition of children access, as well as the lack of outpatient management (e.g. home care) require a careful consideration of the risk/benefi t ratio. Aim: Introduction: The Follow-up is an important part within the treatment of the haematological patient who has undergone a stem cell transplantation. There is no systematic nursing followup or guidelines within our hospital, the Academic Medical Centre (AMC) in Amsterdam, the Netherlands. The period after stem cell transplantation at home is very burdensome and both Somatic and psychological impact is large. We wanted to start a systematic nursing follow-up for patients after autologous or allogenic stem cell transplantation we fi rst wanted to asses the situation in the Netherlands.
NP019 CAREGIVER BURDEN AMONG PRIMARY CAREGIVERS OF PATIENTS UNDERGOING PERIPHERAL BLOOD STEM CELL
Method: We did Literature review to see if there are existing guidelines for these patients in the Netherlands. We developed a survey for haematological patients who have undergone stem cell transplantation We choose 5 questions with multiple answers, to understand which signalling and diagnostic tools should be used for the specifi c complaints to this patient. And one Open question: With the aim that the patient can indicate whether there is a need for a follow up meeting and which topics can be discussed. Results: Follow-up is important for the patient but clear guidelines are not available at this specifi c group in the Netherlands. From the survey that was sent out to 20 patients: 14 (70%) returned (7 allogenic sct and 7 autologous sct.) 4 (20%) not responded and 2 (10%) died. 70 % from the patients needs help for 6 weeks from partner, children and relative after transplantation. (used and side eff ects medication, fatigue, nasea). Most patients (45%) want to have extra support from the nurses, but how we can support this group from the nurses' point of view need to be investigated further. Conclusion and Recommendations: Start with a follow-up meeting 3-6 weeks after discharge to get more insight information what kind of care the patients need after their stem cell transplantation. Using these results we can make progress developing a guideline for these specifi c patients that can be applied in multiple hospitals in the Netherlands. Disclosure of Interest: None Declared. Aim: Psychiatric morbidity in patients with a life threatening hematologic disease are two challenges that require special preparation. About 22 % of Israel's population suff ers from a mental illness. There is no statistical data regarding the prevalence in bone marrow transplant patients. Psychiatric illness is not a contraindication for bone marrow transplant(BMT), however, it may be an obstacle in patient's compliance and as a result increase the risk for complications from the BMT. While determining eligibility for transplantation, using Performance Status Index, we must consider psychiatric disorders as being a substantial risk factor which lowers the overall score. In order to improve patient's compliance and reduce the risk for complications it is important to approach these patients before they enter the transplant. Improving compliance and reducing complications of bone marrow transplant candidates with psychiatric illnesses. Method: We treated 10 patients with various psychiatric illness admitted for bone marrow transplant, at Sheba Medical Center, between January to June 2013. All patients were psychiatrically diagnosed before admission. Patient's compliance to treatment was assessed before, during and 3 months after BMT. Based on the preliminary assessment we created a unique fl ow chart for each patient which included the following data: family and community support, medication used, drug abuse, previous hospitalizations, etc. In addition, it suggested supplementary intravenous medications psychiatric if necessary, according to the psychiatric diagnosis and the expected complications. A case management nurse with palliative care training was appointed to overview treatment. A psychologist accompanied the patient and his family through the process of transplant. Results: All 10 patients were referred to psychiatric and psychologic intake before hospitalization, they were all successfully transplanted and discharged for further follow-up. The individual case management assisted in stabilizing the patient's mental status and preventing complication. 9/10 patient complied completely with the treatment and discharge guidelines. One patient was non compliant, and therefore suff ered from many side aff ects due to the BMT. Comparing these results to a similar analysis performed in 2012 showed a signifi cant improvement in patient compliance. Conclusion: The overall success of a bone marrow transplant strongly depends on the patients compliance. All patients are at risk for complications, but especially in patients with a psychiatric illness. The pre transplant evaluation helps reduce the stress, anxiety & fear, and helps improve patient's compliance. A care manager nurse is cardinal for the support, and complicationprevention of these patients. Aim: Autologous peripheral blood stem cell transplantation (ASCT) in patients with multiple myeloma (MM) is performed in an in-patient setting as a standard of care at our institution. The aim of this analysis is to assess possible benefi ts of patients' discharge from hospital for several days until neutropenia evolves. Method: Two groups of patients with MM treated with ASCT using melphalan (dose between 100 and 200mg/sqm) in 2013 were analyzed retrospectively. Group A patients were discharged from hospital at the day of transplant and then admitted at the onset of neutropenia. Group B patients stayed in hospital for the whole posttransplant period. Patients attitude, incidence of complications, recovery of leukocytes, neutrophiles and thrombocytes, and number of days with antibiotics, parenteral nutrition and opioid analgetics were analysed in both groups. Results: Forty-two patients were included in this analysis. In group A patients were discharged at the day of transplant and admitted day 4 or 5 after transplant. Seventeen patients reported no diffi culties during the out-patient period at all. There was a lower risk of thrombosis, infection and antibiotic use in the whole posttransplant period. The need of parenteral nutrition was similar in both groups. Conclusion: Combined out-patient and in-patient setting in patients with multiple myeloma after autologous peripheral blood stem cell transplantation is a convenient and safe way to manage, both for the patient and the nursing staff . In addition, there is the increasing pressure to deliver safe high quality patient care that is cost eff ective and patient-centred in its approach to future proof services. This is consistent with the evolving global perspective that the merits of healthcare providers cannot be based simply upon clinical outcomes but must also clearly demonstrate optimal patient experience. Method: The concept of 'one size fi ts all' is not a viable solution to meeting confl icting healthcare demands and presents a challenging problem, particularly in relation to resource allocation (Keogh, 2013) . The sharing of information and collaborative working to promote best practice is key to the successful implementation and sustainability of any new care delivery initiative. The planning and implementation of the Ambulatory Care project has been a challenging process in relation to agreeing inclusion criteria, resource allocation (monetary and staffi ng), bed capacity/ increased activity, infrastructure/facilities, and managing patient expectation, as well as, increased demands placed on the professional development of the multi-disciplinary team to meet the new service requirements. In addition the organisation has undergone a complex and extensive reconfi guration of services all of which impacts upon productivity. The planning process has involved a great deal of preparative work and has required signifi cant commitment from the team to maintain momentum and focus, whilst formulating policy and treatment pathway regimens that meet the standards for safety and quality assurance set by various regulatory bodies. This process has also included coordinating visits to other centres, and sharing experiences in this evolving fi eld. Conclusion: For Imperial College Healthcare NHS Trust the key drivers have been to improve clinical and operational eff ectiveness by redesigning treatment pathways to enhance patient experience. To this end, our project has been ambitious as it includes the implementation of a 24 hour helpline for all patients with a haematological malignancy, Triage & Assessment unit incorporating the use of UKONS tool kit, day pain service for patients with sickle cell disease and shifting suitable in-patient treatment pathways into a seven day a week ambulatory care model for healthcare delivery. Maximising resources without decreasing quality remains a challenge but we remain positive that these changes, which place the patient at the centre of service improvements, will ensure the best patient outcomes. ) over a 35 month period (Jan 11 to Nov 13) to identify expected harvesting dates as well as average stem cell yields (CD34 x 10 6 /kg). We compared actual harvest day(s) against the estimated harvest day(s) on our current mobilisation protocols. Regime details:
NP023 FERTILITY AND SEXUAL FUNCTION IN FEMALE HODGKIN LYMPHOMA SURVIVORS OF REPRODUCTIVE AGE
DHAP: D1-4, GCSF Zorzia 5mcg/kg from D7, expected Harvest D14. MiniBEAM: D1-6, GCSF Neupogen 5mcg/kg from D12, expected Harvest D18. AraC: D1-3, GCSF Filgrastin 5mcg/kg from D5, expected Harvest D12 IVE: D1-3, GCSF Neupogen 5mcg/kg from D4, expected Harvest D14. Cyclo 4g/m 2 : D1-2, GCSF Filgrastin 10mcg/kg from D7, expected Harvest D13. All (N=37) but 1 patient, were successfully harvested and yielded suffi cient stem cells at >2 CD34 x 10 6 /kg. The harvest day for DHAP and cyclo 4g/m 2 fell closest to the predicted harvest day. However, the actual harvest day for Mini-BEAM, AraC and IVE was less predictable than expected.
Conclusion: This small sample shows that some chemotherapy mobilisation regimes (DHAP, Cyclo 4mg/m 2 ) are more predictable in terms of harvesting days whereas the other regimes examined demonstrate a much wider variance with some patients taking more than 7 days and as many as 12 days longer than 'expected' . A larger sample might generate further useful data and other variables not examined in this audit might also infl uence predictability. From our fi ndings, we will continue to book for 3 days harvest slot for DHAP and Cyclo 4g/m 2 mobilisation but maintain a fl exible approach to accommodating the other regimes. Disclosure of Interest: None Declared. Aim: Platelet Depletion is a therapeutic apheresis procedure that is not performed very often in our apheresis suite. Platelets are colourless cells circulating in the blood. They are able to change shape and become sticky and they contain many structures that are critical to stop bleeding. By adhering to torn blood vessels and sticking together they create a plug and slow the loss of blood. Blood disorders such as essential thrombocytosis and some forms of leukaemia can produce excess platelets. Normal platelet count range is 150-350 x 10 9 /l. In some blood disorders the platelet count may reach above a million. Platelet depletion is a standard procedure for dangerously elevated platelet levels that cause symptoms such as clotting or bleeding.
NP029 PLATELET DEPLETION: THE IMPERIAL COLLEGE HEALTHCARE NHS TRUST EXPERIENCE
Apheresis is separating the blood in its diff erent components by centrifuging it through an apheresis machine. This enables the practitioner to collect desired cells and infuse the rest of the cells back to the patient. In therapeutic platelet depletion procedure the Spectra Optia apheresis machine is confi gured to only collect the excess platelets. Method: Earlier this year the apheresis team had the challenge and privilege of performing platelet depletions on a 57 year old female newly diagnosed with Chronic Myeloid Leukaemia (CML) in chronic phase. Her blood counts on presentation were: White Blood Cells (WBC) 2.9 x 10 9 /L, Haemoglobin (Hgb) 87 g/L, platelets (Plt) 3500 x 10 9 /L, neutrophils 2.0 x 10 9 /L. She was experiencing vertigo and dizziness, and had extensive bruising on left calf. A Computer Tomography (CT) scan of her head was unremarkable as was her chest x-ray and an Ultrasound scan performed of left calf. The patient was referred to us for platelet depletion on 06/06/13. The procedure was uneventful. Post Plt count 1351 x10 9 /L. No complaints of vertigo and dizziness. The patient was discharged back to her local hospital. On 11/06/13 the same patient was admitted at Hammersmith Hospital with breathlessness and tachycardia. CT scan showed no evidence of pulmonary embolism. Plt count 2241x10 9 /L. 2nd platelet depletion was eff ected. It was uneventful albeit slow due to tachycardia and breathlessness. At this point Anagrelide and tyrosine kinase inhibitor were added. The patient is doing well at present with 6 monthly haematology reviews. Results: This challenge coincided training I was doing with one of our junior nurses. Three issues emerged: Citrate toxicity, safety, training and ongoing apheresis education. Conclusion: erapeutic platelet depletion is a safe procedure but side eff ects can occur. As it is a long procedure the common side eff ects are mainly due to Anticoagulant citrate dextrose formula A (ACD-A) reactions such as tingling in fi ngers and peri-orally, nausea and dizziness and feeling cold. Serious complications such as cardiac arrhythmias and seizures, though extremely rare, remain a clinical reality. Disclosure of Interest: None Declared. All patients harvested in one day unless otherwise specifi ed. *2 patients required two days harvest, 1 required three days harvest. **2 patients require two days harvest and 1 patient failed to mobilise.
NP030 VALIDATION OF PBSC COLLECTION WITHIN JACIE PROGRAM: A MULTICENTER EVALUATION
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Method: We retrospectively evaluated a total number of 67 collection procedures both from IEO (Italy) and IOSI (Bellinzona, Switzerland) performed by Optia by estimating the effi ciency of the procedure in terms of the fi nal yeld of CD34+cells achieved related to the number of CD34+ processed by the machine. This method involves the determination of the total blood volume (TBV) processed. At the start of the collection procedure, the Optia machine calculates the donor's estimated TBV as a function of height and weight. The actual number of TBVs processed during a specifi c apheresis procedure is easily available from the fi nal procedure data provided by the machine at the end of the run. Therefore, we estimated "Total Number of CD34+ cells processed" multiplying the number of TBVs processed by the donor's peripheral CD34+ cell count on the day of collection. Then we investigated if the fi nal CD34+ cell dose in the aphaeresis product can be expressed as a function of this derived value for CD34+ cells processed, plotting values in a scatter diagram. As the Total Blood Volume is dependent on the donor's size, the fi nal CD34+ cell dose in the product also has to be size-adjusted by expressing it as CD34+ dose per kg bodyweight. Results: We observed a good linear correlation between the two variables, so, using the equation determined by diagram, we prepared a Aim: To determine harvest effi ciency of Cobe Spectra® ("Cobe") versus Spectra Optia® ("Optia") in terms of collection volume required to meet target dose with consideration of the cost of processing and storage fees.
Method: Apheresis harvest records, Stem Cell Lab data and clinical engraftment data were analysed retrospectively for 34 consecutive harvest procedures (17 Cobe Spectra AutoPBSC, 17 Optia MNC version 7) for the period September 2011 to July 2013. Results: The two cohorts were well matched in terms of diagnosis, age, gender and mobilisation regimes. Pre harvest WBC and peripheral CD34+ counts were comparable (WBC median 21.7x10 9 /L Cobe; median 19.1x10 9 /L Optia; Peripheral CD34+ Optia median 34x10 3 /mL and Cobe median 32x10 3 /mL). An increase in the Optia CD34+ yield of median 2.55x10 6 /kg was noted compared with 1.69x10 6 /kg for the Cobe. The Cobe cohort median harvest volume was 109ml compared with 194ml for the Optia resulting in an average of 3 bags for Cobe and 5 bags for Optia requiring cryopreservation storage. Processing and storage costs are calculated per bag which results in a cost increase associated with Optia. However, 69% of Optia patients achieved target dose appropriate for transplant in a single apheresis day compared with 40% of Cobe patients. A reduction in median apheresis days has been observed from 2 days on the Cobe to 1 day for the Optia creating a cost saving in terms of processing fees, cost of disposables, as well as apheresis and courier services. In both cohorts approximately 50% of patients received reinfusion of their total collected dose within the year. In cases requiring ongoing storage an increased fi nancial implication associated with Optia harvests has been noted due to greater number of bags. The Optia harvest volume could potentially increase the total Dimethyl sulfoxide (DMSO) dose per kg. Due to restrictions in re-infusion of DMSO related to patient body weight we have observed two patients requiring re-infusion of cells over two days, incurring additional issuing fees from NHSBT. The majority of patients from both cohorts have proceeded to transplant with comparable engraftment times (Cobe median ANC 13 days, Platelet 10 days; Optia median ANC 12 days, Platelet 13 days). There were no episodes of failed engraftment. Conclusion: Overall, in our experience the Optia appears a viable fi nancial replacement for the Cobe with an observed improvement in harvest effi ciency. Incidentally, the increased harvest volume of the Optia has led to closer evaluation from our haematology consultants when deciding optimal doses for patient's PBSCT and ongoing storage requirements. Disclosure of Interest: None Declared. On average each year 150 autologous and 30 allogeneic stem cell collections, 280 plasma exchanges, 35 red blood cell aphereses and 10 white blood cell depletions are performed. As the largest apheresis center of the Netherlands a lot of knowledge and experience has been gained. We consider dissemination of knowledge and experience an essential part of our apheresis nurses' job at the Erasmus MC Cancer Institute. Therefore we have decided to become a "Demonstration Centre", to share our knowledge and skills on the diversity of procedures all performed with the apheresis machine Spectra Optia (Terumo BCT). Method: 1. Internal: Educate nurses enrolled in a oncology/ hematology training, and interested nurses of other departments by giving clinical lessons. 2. Because of a collaboration agreement nurses located at an external department are practically trained and tested.
NP032 TRANSFER OF KNOWLEDGE ON APHERESIS IN
3. External: transfer of knowledge and sharing practical experience with apheresis staff from other centers, by demonstration of the Spectra Optia in daily operation. The purpose is to give them a possibility to further improve skills and knowledge.
Results: 1. Provide knowledge about the background and practical issues of the various apheresis procedures 2. After appropriate training nurses are able to perform procedures at our hemapheresis department independently. By giving the opportunity to apheresis staff from external centers to share questions about procedures, collaboration between diff erent apheresis centers will be improved. Conclusion: Transfer of knowledge is a very important aspect of the job roles of the apheresis nurses of the Erasmus MC Cancer Institute resulting in internal and external training to apheresis staff and nurses. By sharing knowledge and experience collaboration will be strengthened. This contributes to the improvement of the quality of donor-, and patient care in the apheresis unit, not only in the Erasmus MC Cancer Institute, but also to other apheresis departments in the Netherlands. Disclosure of Interest: None Declared. Results: 11 of 20 patients collected enough cells for 2 transplants while the remainder only had suffi cient yield for a single procedure. Unexpectedly, a 3rd collection day was only undertaken in 5 patients and although 2 of these did yield suffi cient cells for a second transplant, the remainder collected enough only for 1 transplant procedure. 2 patients completed their harvesting for 2 transplants in a single Apheresis. Average total CD34 x10 6 /kg collected was 6.9 (range 2.9-11.1) and the average cell dose for the 1 st infusion was 4.6 CD34 x 10 6 /kg (2.9-8.0). 9 patients received all their cells in a single autologous procedure. At transplant, all patients received a good cell dose at 4.6 x10 6 CD34/kg (2.9-8.0) and regenerated in a timely fashion at D+17 (12-25). Conclusion: The 3 day harvesting procedures were well tolerated in the 5 patients who underwent them. The audit fi ndings suggest 11/ 20 patients were able to collect enough cells for 2 transplants and only 2 of these 11 needed a 3 rd collection day. No patients required transfusion support to complete Apheresis and no other adverse eff ects were reported. At transplant, cell dose given and time to engraftment were not compromised by cell retention for the planned second autologous procedure. This is a reasonable and eff ective approach with the aim of achieving long term progression free survival which has been demonstrated using tandem autologous transplantation. Aim: Dendritic cell (DC) vaccines provide a promising experimental therapy for a range of malignancies. Collection of large numbers of monocytes is necessary and high collection effi ciencies ensure this can be accomplished in a single apheresis procedure. We compared product quality and key performance metrics obtained from two devices. Method: Between 2012 and 2013, monocyte collections from nonmobilized patients were performed for a range of clinical indications. COBE Spectra (CS) and Spectra Optia (SO) devices were used for all procedures. Pre, post and product cell counts and procedure data were stored for each collection. Performance metrics were generated and appropriate statistical comparisons were made using Chi square, unpaired t-test or Mann Whitney for non-normal distributions. Results: In total, 42 procedures on SO were compared against an historical control of 125 procedures on CS. There were no signifi cant diff erences between the two groups for patient weight, total blood volume, pre-apheresis cell counts, vascular access, clinical indication or volume of whole blood processed. Average procedure time was signifi cantly longer on SO than CS (222min vs. 190min p<0.001). Final average monocyte purity (21.8% vs. 20.0%) and monocyte CE1% collection effi ciency (55.7% vs. 49.1%) were both higher on SO compared to CS, but not statistically signifi cant (p=0.05). Total monocyte yield was also higher on SO than CS but this also did not reach statistical signifi cance (2.34 x 10 9 vs. 2.15 x 10 9 p=0.4) Average non-target cell collection effi ciencies were significantly lower on SO than CS for Granulocytes (0.9% vs. 1.6% p=0.03) and Platelets (12.0% vs. 22.4% p<0.001). Product haematocrit was also lower on SO than CS (2.3% vs. 3.3%) Despite similar volumes of blood being processed during apheresis, signifi cantly lower product volumes were generated on SO than on CS (101mL ± 19mL vs. 130mL ± 35mL p<0.001) ( Table 1) . Conclusion: During apheresis, precise interface identifi cation, management and control is critical for optimal collections. This can prove challenging in non-mobilized patients with normal or low numbers of circulating mononuclear cells (MNC). Spectra Optia uses an automated interface management (AIM) system whilst COBE Spectra relies on frequent operator controlled interface adjustment. Spectra Optia collected large numbers of monocytes in a single apheresis session delivering products suited for use in DC vaccine production and showed signifi cant benefi t 
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versus COBE Spectra by delivering higher purity fi nal products in smaller product volumes, with less red cell, granulocyte and platelet contamination and resulted in signifi cantly lower losses of platelets to the patient during the procedure. Disclosure of Interest: None Declared. Aim: To audit compliance with the current standard operating procedure (SOP) for donor work-up and evaluation and to assess the work load associated with related donor medicals and their contribution to transplant delays. Method: A retrospective audit of related donor medicals prior to peripheral blood stem cell harvesting performed at King's College Hospital, London, between October 2012 and October 2013. Data were collected from the medical notes. Results: Twenty-fi ve donor medicals were preformed on 11 females and 14 males. The average age was 47 years (range 29-68 years). Twenty-two were siblings, 2 were off -spring and 1 a parent. Fifteen donors had no co-morbidities, 8 had one co-morbidity and 2 had two co-morbidities. All but 2 patients had all the required investigations performed as stipulated by the SOP. Twelve donors (48%) required further investigations due to abnormal tests. Seven required repeat blood tests. For 4/7 donors this was for hepatitis B DNA as initial blood tests were consistent with past exposure to the virus. In the other 3/7 donors a repeat full blood count (FBC) was performed for an elevated MCV, neutropenia and neutrophilia/thrombocytosis, respectively. Three patients went on to have bone marrow aspirates and trephines due to an abnormal FBC; 2/7 had normal results and 1/7 was consistent with a myelodysplastic syndrome. Five donors had an abnormal ECG, which warranted an echocardiogram (ECHO). Four of the 5 ECHOs performed were normal and 1 was abnormal, but the latter did not prevent stem cell donation. Four donors were not medically cleared for donation; 1 for possible MDS, 2 for raised MCV (departmental policy), 1 for active hepatitis B infection. Twentyone donors were deemed fi t to donate stem cells and of these 18 have completed harvesting, 2 are awaiting harvest, and 1 has been cancelled due to disease relapse in the recipient. For the 21 donors cleared to donate, the median number of days from fi rst visit to medical clearance was 16 days (range 2-58 days). Eight of the 21 donors were able to donate on the pre-booked harvest dates. Thirteen donors were delayed by a median of 14 days (range 7-135 days). This was due to donor-related issues in 7 cases and recipient-related issues in 6. Three donors attended accident and emergency for bone pain following G-CSF administration. One was noted to have splenomegaly. Conclusion: Adherence to the local donor work-up SOP is good. Co-morbidities are prevalent in the related-donor population with the potential to delay planned transplant procedures. Donor assessment needs to begin earlier in the transplant coordination pathway. Improvements to the current donor selection questionnaire and telephone interviews prior to donor selection could help to identify issues that may hinder donor clearance. Disclosure of Interest: None Declared. Aim: Mucormycosis is a rare infection caused by organisms that belong to a group of fungi called Mucoromycotina in the order Mucorales. The infection is more common among people with weakened immune systems especially with neutropenia, and as such, cancer and haploidentical hematopoietic cell transplantation (HCT) are typical. Treatment usually includes combination of anti-fungal agents and thorough debridement of the infected area. Method: Eleven year old child was diagnosed as suff ering from myelodisplastic syndrome and acute myeloid leukemia. Due to lack of matched related donor, he underwent haploidentical HCT from his mother and engrafted on day +14. Unfortunately, the graft was rejected on day +26. While neutropenic and during preparations for a second transplant, he developed left gingival hyperemia, gingival pain and fever. Surgical debridement revealed necrotic material adjacent and around teeth number 35, and in pathology -mucormycosis with no evidence of leukemia. The patient started caspofungin and continued another 4 surgical debridement procedures in the next 33 days. Nevertheless, acknowledging the importance of neutrophils in controlling such infections on one hand, and the long time until engraftment that was expected in this patient on the other hand, he received 16 granulocyte transfusions over that period of 33 days. Granulocytes were harvested from adult volunteers using granulocyte-colonystimulating-factor (G-CSF) and dexamethasone. Every harvest was divided into 2 doses given every 12 hours. Results: Mucor infection was controlled and gingival lesions disappeared during granulocyte transfusions. While on treatment, the patient underwent a second haploidentical HCT from his father and engrafted on day +8 with 100% donor chimerism. Last pathological examination demonstrated fragments of granulation tissue, mucus, fi brin and infl ammatory cells with no evidence of fungal infection. Conclusion: Granulocyte transfusions by G-CSF-stimulated donors while waiting HCT should be considered in patients suff ering from life-threatening fungal infections. Disclosure of Interest: None Declared.
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Education for Patients
NP037 SURVEY OF EDUCATIONAL NEEDS INVOLVES PATIENTS AFTER BONE MARROW TRANSPLANTATION
Ematology and BMT Unit, San Raff aele Scientifi c Institute, Milan, Italy
Aim: This study has the aim to identify the educational needs of the adult allogeneic bone marrow transplantation (BMT) patients appeared during the fi rst six months after transplant. Method: The BMT recipients are at risk of severe complications, not only during the hospitalization, but also after the discharge (Laff an et al, 2006) . The late complications are frequently related to cytotoxicity due to the chemotherapy and concern renal, gastric, endocrine, muscle-skeleton functions, graft versus host disease (GvHD) and bacterial, fungal and viral infections. Through the therapeutic education, the nurses provide to patients and family adequate tools in order to develop their self-care skills for improving the quality of life. The study involved San Raff aele Hospital patients during summer of 2012 and consisted in fact-fi nding survey composed by a complete bibliography review on the contents and the collection of data through semi-structured interview regarding the following fi elds: general data, complications/problems and compared symptoms, knowledge about acquired information and owned resources (caregiver). To the participants was required the informed consent and guaranteed the anonymity and data confi dentiality. The obtained quantitative and qualitative data were analyzed through statistical methods. Results: 18 Interviews were performed to 25 and 63 years old patients (10 mans and 8 women). As concern the survey fi elds, the most frequently symptoms were the fatigue and skin and mucosa problems, strictly connected with chronic GvHD. The patients reported that the owned knowledge about complications/problems were sometimes not completely suffi cient and came from medical staff during follow up visits, from nurses during the hospitalization for BMT and from admit/discharge informative brochures lecture. Entirety of patients was assisted by caregiver at least the fi rst month after the discharge and sustained the importance of his/her specifi c training. Conclusion: The survey of patients educational needs allowed us to implement the actual informative brochure guide concerning with the discharge period after BMT and underlined the necessity to identify dedicated nurses for the therapeutic education oriented to transplant patients. This educational activity could be perform to every single patient and caregiver at specifi c outpatients clinic with dedicated spaces and times in order to guarantee an adequate and continuous nursing support after transplant. Disclosure of Interest: None Declared. Aim: Since 2010, an approach step by step has been performed by a collaborative team in the aim to improve the patients (pts) information (IF) and the comprehension of pts concerning discharge instructions (abstract n° 253, EBMT 2011). To improve pts care, the nurse of transplant unit elaborated with the medical team, a booklet with the objective to educate transplant pts after leaving hospital. An evaluation of this education has been performed in 2013 in order to adjust and improve the content of IF delivered to pts. To assess satisfaction and comprehension of pt using booklet of discharge allograft instructions and its usefulness of using the information included in the guidelines for answering to pts needs. Objectives: To present the development and application of multimedia tool used to assist in the patient education at the pre HSCT assessment at a center in the state of São Paulo, Brazil. Method: Started building the multimedia classroom involving the medical staff , nursing and area responsible for media and patient education. The fi rst step was the content organization it was divided into four modules : Introduction -addressing general concepts, indications and types of transplants; The procedure talks -about hospitalization, catheters, conditioning, infusion, complications, readmissions causes; The Unit Presentation -brings photos and explanations of the unit diff erential the environmental control and fi nally The general guideline -with companions rules and practices, feeding structure and what should bring or not at the admission. The next step was recording the audio in a video conferencing room, then editing and fi nal release DVDs with total time of 20 minutes.
NP038 EVALUATION OF A DISCHARGE INSTRUCTION BOOKLET FOR ALLOGRAFT PATIENT
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Results: We begin the application of multimedia classroom with educational video at the beginning of year 2013. We did a multidisciplinary approach on the pre HSCT outpatient eventually in inpatients. It begins with the presentation of educational video via laptop, after that the nursing staff answer questions and if necessary supplement to the guideline, the delivery of support materials written and printed manual is the last part. The patient goes to a doctor and the other members that make up the multidisciplinary team, in the case of pediatric patients the video is presented to parents or guardians. Conclusion: Patients and staff members have reacted positively, absorption of this educational tool, clarity and retention of information was observed, as well it can be used as a systematic roadmap with relevant complete information to this stage of the transplant process optimizing the working of the team involved in the pre HSCT. Disclosure of Interest: None Declared. Aim: There is a growing recognition that the perception of AYAs diagnosed with cancer is distinctive from that of children or adults. The main objective of this project is understanding how AYAs and their care giving parents experience cancer, diagnosis, hospitalisation, treatment and survivorship to develop a patient centered tool which can be used by the multidisciplinary team. Method: A qualitative study was performed based on the principles of grounded theory. 24 semi-structured interviews were held with AYAs between 15 and 25 years of age. Additionally 21 care giving parents (19 mothers and 2 fathers) were interviewed. Sampling was based on situational diversity (e.g. gender, age, social context, education, time since diagnosis). The interviews were transcribed and coded (NVivo7) and constant comparison was used to analyse the data. Data collection and -analyses took place in a cyclic process. Results: From the AYAs' perspective, cancer is something temporarily passing their life-path. Their coping strategies are focused on preserving identity and guarding normal life, not only during treatment, but also in follow-up and survivorship. Findings suggest that AYAs prefer care, tailored to their needs. The AYA box has been developed to meet these specifi c needs and to enhance the communication with the AYA. The box belongs to the AYA only and contains a booklet with revealing stories of AYAs' experiences, postcards, a unique AYA tag, useful stickers mention feelings or concern, cards with information or instructions, a brief symptom scale and smart aids in communication with their relatives and professional caregivers. The whole multidisciplinary team work with this instrument and can use it to talk about more diffi cult or emotional topics. When confronted with the cancer of AYAs, the care giving parents face various fears and insecurities. In relation to each other fi ndings demonstrate poor communication about emotions between the AYAs and the care giving parents. The box can provide a means to promote this communication. Conclusion: This study revealed that cancer seems to have a diff erent meaning for AYAs than for their care giving parents. The results are translated in a practical box, based on the experiences of the AYAs and can inspire caregivers to provide patient centered care in accordance to the specifi c preferences and wishes of the AYA. Disclosure of Interest: None Declared. Aim: The aim of this pre-transplant information guide is to complement and reinforce the information provided at outpatient visits regarding hospital admission for hematopoietic stem cell transplant (HCT) in our center. The knowledge, involvement and participation of the process of HCT by the patient and their relatives is essential to have the best chances of success both in autologous and allogeneic, related and unrelated. Health education provided by clinical nurse is an essential part of the work of the multidisciplinary team (MDT). Method: A transplant MDT led by the bone marrow transplant clinical nurse specialist (BMT CNS) developed this guide in 2010 and later revised in 2012. The MDT consisted of: the clinical team of HSCT, the nursing head of hematology unit, the nutrition functional unit, a physiotherapist, an infectious disease specialist, a psychologist and a nurse health education program. The guide is directed to patients and their families and includes valuable information for the hospital admission with the following key points: feeding during hospitalization, hygienic measures and isolation, the description of the MDT and defi nition of links after discharge. The BMT CNS provide this guide at the nurse outpatient pre transplant clinic and is structured into the following sections: -Unit and health care team: the transplant unit where the patient will be hospitalized and the MDT.
NP040 THE AYA BOX: A PATIENT CENTERED INSTRUMENT IN COMMUNICATION WITH ADOLESCENTS AND YOUNG ADULTS (AYA) WITH CANCER AND THEIR CARE GIVING PARENTS
NP041 NATIONAL POST-TRANSPLANT FOLLOW-UP CARE LOGBOOK FOR PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN INITIATIVE BY THE SFGM-TC
-Unit admission: all patient protection measures both general and specifi c in our hospital. Special mention for food, isolation and infection prevention.
-A day in the transplant unit: the general dynamics during hospitalization. The most common activities and routine health care team.
-Introduction to hospital discharge: ambulatory and continuous monitoring and mentions the discharge guide.
Results: From January 2010-October 2013 this patient guide has been applied to 240 patients with HCT: 151 auto, 89 allo, (48 related, 41 unrelated) with a median age 54 (20-71),101 women and 139 men. Guide discussion took place at the nursing pre transplant outpatient clinic. Feedback on the information provided in the guide were collected by the CNS who noticed that it helped to reduce anxiety and fear generated by this process and fostered a climate of confi dence between patient and clinical staff , contributing to a better understanding of the HSCT and strengthening the patient's adaptation, adherence and involvement in care. Conclusion: Our experience at the Institut Català d'Oncologia is that this tool will increase the involvement of both the patient and the family in care related to the HSTC because it helps to understand the information provided by the CNS and make a practical and durable link between the patient and the MDT. The next goal is to prospectively evaluate the tool using qualitative and quantitative indicators that make us better target care clinical nurse specialist. Disclosure of Interest: None Declared. Aim: The aim of this oral presentation is to describe our patient education program that provides continuous consultation services from pre-admission diagnostics through late eff ect issues in the fi rst 5 years after the allogeneic stem cell transplantation. Method: We will discuss our clinic's patient education program methods of guiding patients through the multifaceted learning process of understanding and coping with allogeneic stem cell transplantation. Emotional readiness and anxiety levels are dynamic throughout the transplantation phase. Not all patients learn eff ectively during inpatient therapy. Recognizing these factors, nursing staff in our clinic are appointed to work in dual inpatient and outpatient positions. Results: By establishing contact with patients in the pre-admission phase and building trusting relationships that continue through the fi rst years after transplantation, comprehensive and individualized patient learning sessions are a result. Conclusion: In summary we will present the organizational hurdles and constructional benefi ts of implementing a patient education program with nursing staff in dual inpatient and outpatient positions. In providing access to patient education from pre-admission to post-discharge, the patient is allowed extended timeframes needed to capture eff ective learning moments in understanding and coping with allogeneic stem cell transplantation disease processes. Aim: The recipients of Hematopoietic stem cell transplantation (HSCT) required a stable vascular access for drug administration, and many of them depends on Center Venous catheters (CVCs) or other long-term indwelled devices. However, the accompanying central line-associated bloodstream infections (CLABSIs) can be associated with increased morbidity and mortality in these patients, because of their compromised immunity after treatment. For their safety, an action to "getting to zero" of CLABSI is very important. We are here going to illustrate the benefi cial impacts of our "getting to zero" action on the rate of CLABSI in our HSCT units in National Taiwan University Hospital in Taiwan. Method: According to 2011 Center of Disease Control (CDC) guidelines for CLABSI and the central line care bundle by the institute for healthcare improvement (IHI), we fi rst emphasized our prevention measures, after January 2012, with the following items: hand hygiene, maximal barrier precautions insertion, preparing clean skin with a 2% chlorhexidine in alcohol before insertion and during dressing changes, optimal catheter site selection, proper catheter maintenance, and daily review of line necessity with prompt removal of unnecessary lines. From July 2012, we start to apply the chlorhexidine-impregnated sponge dressing for the wound of catheter entrance, and its impacts on decreasing the rate of CLABSIs is reported.
NP043 START TO FINISH NURSE CONSULTATION: A PATIENT EDUCATION STRATEGY TRANSCENDING FROM PRE-ADMISSION TO POST-DISCHARGE CONTACT
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Results: The baseline CLABSI rate in the 2011 (before action) was 7 per 1593 catheter-days (4.39‰). At the fi rst stage from January, 2012 to June, 2012, the rate of CLABSIs was successfully decreased to 1 per 710 catheter-days (1.41‰). After changing the dressing to chlorhexidine-impregnated sponge, the CLABSI rate was 1 per 733 catheter-days (1.36‰) from July to December in 2012. The rate of CLABSI (1 per 1109 catheter-days (0.90‰)) was even lower from January to September in 2013 under the use of chlorhexidine-impregnated sponge. Conclusion: The encouraging results in our "getting to zero" action for CLABSIs demonstrate an excellent example that the improvement of training and materials in nursing care standards can benefi t the outcome of patients receiving HSCTs. Disclosure of Interest: None Declared. These have included changes in the types of dressings used (from transparent dressings to chlorhexidine gluconate based dressings), frequency of dressing changes (from 48 hours to 7 days), cleansing solutions (from the use of povidone iodine to chlorhexidine 2%), infusion set changes (from daily changes to every 72 hours). We observed that overall, the incidence of CVC related bacteremia has reduced over the years. However, we have also noted that there have been small peaks (an increase 2 or 3 cases) of incidence of bacteremia at the same time as either one of the above mentioned changes in CVC management has been implemented, or where staff new to the area are receiving CVC training, or in periods where staffi ng levels were low -an observation confi rmed in the literature. Conclusion: The use of clinical indicators has allowed us to have an accurate account of CVC related bacteremia and CVC infection related symptoms. The extraction and presentation of data on a 3 monthly basis allows for a timely recognition of issues and problems. It also allows the team to identify where improvements in practice can be made, in this case, ensuring that best practice is observed during times of low staffi ng, and that CVC management training is ongoing. Disclosure of Interest: None Declared. Aim: The fi rst Hematopoietic Stem Cell Transplant (HSCT) at the University of Benin Teaching Hospital Nigeria was carried out in 2011 and a total of three HSCT have been done as at 2013. The eff ective Nursing management of CVC is crucial to the successful outcome of HSCT especially in a developing centre where CVC is still a new procedure. Method: Meeting the EBMT standards for dressing of CVC is diffi cult in a developing centre where good antiseptic solutions are not readily available. The fi rst HSCT patient developed pseudomonas infection at the site of femoral catheter which was cultured from the chlorohexidine antiseptic. Patient catheter was removed and responded to ofl oxacin (antibiotics). The Nurses in the unit developed a protocol with the use of methylated spirit (100%) as antiseptic to clean the surface of the catheter site and the surrounding including the catheter tubes.
NP046 CENTRAL VENOUS CATHETER-RELATED COMPLICATIONS AFTER BONE MARROW TRANSPLANTATION IN PATIENT WITH HEMATOLOGICAL MALIGNANCIES
NP048 NURSING CHALLENGES IN THE CARE OF CENTRAL VENOUS CATHETER (CVC) FOR HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS IN
Results: The methylated spirit as an antiseptic was noticed to be eroding the catheter tubing causing breakage and leakage of the tubes. This resulted in emotional stress and frequent changing of the catheter with its attendant complications of the procedure. A new protocol was developed by the nurses with the use of iodine Tincture (2.5% w/v of iodine in isopropyl Alcohol B.p) which was aff ordable and easily available. This gave us a better result and there was no more leakage of the catheter. Conclusion: Despite these challenges, the Nurses have introduced a protocol with the use aff ordable and available material at our disposal to maintain adequate care of the CVC. Disclosure of Interest: None Declared. Results: The educational function, clinical confi dence, self-reliance and leadership seem to be a task force of the nurse consultant perceived as an agent of cultural change; narrative surveys and interviews showed that both the role of the consultant and its integration in the health system need to be further clarifi ed. The general skills pillar that a nurse consultant must have: education and training, leadership, practice expert, search functions and development of services. Conclusion: Generalizing the data obtained in the fi eld of vascular access, are deduced the essential requirements that the consultant nurse must possess in order to ensure the health of the patient's hematologic vessel.Recommendations and guidelines enable the nurse to provide specialist services after reaching technical -skill-set but the nurses become expert can also provide multi-disciplinary relations consultancy? What are the particular professional task to be acquired, as well as the technical and practical, so that a nurse can be an expert consultant who performs an educational function, lends advice in vessel health on the basis of diagnosis, treatment and patient characteristics?
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The literature recommends further deepen the impact of nurse consultant on health outcomes of the patient by measuring the perceived quality in vessel health. Disclosure of Interest: None Declared. Aim: The use of central venous catheters (CVC) is essential for best management of the patient's hematologic subjected to transplantation hematopoietic progenitor cells (HPC). The positioning of the CVC is a maneuver is not without its risks and its maintenance in the medium and long term can be difficult in the context of home management. The use of Peripherally Inserted Central Catheter (PICC) can greatly simplify the management of PZ underwent transplantation for which, during hospitalization is planned an intensive treatment program, which continues after discharge, outpatient and day -hospital. Method: The main objective is to evaluate the applicability, functionality and maintenance of the PICC in the transplant patient of HPC. L 'indicate the placement of the PICC was essentially the accessibility of a basilic vein or, second choice, a vein in your arm in all patients undergoing autologous or allogeneic transplantation of HPC. Patients not meeting this criterion were receiving the insertion of a CVC alternative. For autologous HPC were used PICC 4 fr lumen open toe, for allogeneic transplants have been used PICC 4/5 fr lumen open toe and closed toe. In all cases, the positioning has been performed with the method eco guided and modifi ed Seldinger technique. All patients gave their informed consent to the inclusion of PICC. Results: From 1 October 2010 to 25 October 2013 were evaluated 238 consecutive patients of which 88 patients had a CVC already inserted, the remaining 150 patients, after evaluation, 126 had inserted the PICC (85%). Of the 126 patients who entered the PICC, 57 received a transplant of autologous HPC and 69 Allogeneic transplantation of HPC. 7% of the patients had severe thrombocytopenia (<20,000 plts / mmc). The vein of choice for the positioning of the PICC was the basilica in 77% of cases. The median duration of PICC was 117 days (range 10-518 days). Are currently in use without any type of complication 22 PICC, the duration of which is the median of 112 days.The incidence of bacteremia associated to removal of the PICC was 0.066 per 1000 days / catheter. The incidence of removal for thrombosis was 2.9% (3 PICC). The incidence of removal for malfunction (migration -obstruction) was 8.7% (9 PICC). Conclusion: The exclusion of the risk of pneumothorax, the low impact of thrombocytopenia on complications from positioning, the low incidence of associated infections and related thrombotic episodes and, fi nally, the ease of removal encourage the use of PICC in the patient subjected to hematology Transplant HPC. Aim: The aims were: to obtain a snapshot of clinical practice guidelines adopted within the GITMO transplant centers, to verify S418 compliance with the key international guidelines surrounding protective isolation, to disseminate the survey fi ndings. Method: In 2007, the GITMO Nurses Group launched a project to identify clinical practice regarding protective isolation within specifi ed areas in GITMO transplant programs. We sent 2 questionnaires using open-ended questions, to the GITMO nurse delegate of each transplant program. One questionnaire was related to autologous SCT and the other to allogeneic SCT. Topics covered within the questionnaires were: environment & structure, guidelines for patients undergoing stem cell transplant (SCT), guidelines for staff , guidelines for visitors, and dietary guidelines. Findings showed discrepancies between practice and evidence based guidelines, and as such, the GITMO Nurses Group delivered educational events in which these topics were discussed. The aim was to promote Evidence Based Practice and raised awareness of existing international guidelines. After the educational interventions, the survey was repeated in 2009 and again in 2013. Here we present the results of the 2013 surveys. Results: We received 60 questionnaires relating to allogeneic SCT and 68 relating to autologous SCT. Discrepancies between clinical practice and international guidance was noted. The most important areas highlighted, in which the literature is well defi ned, relate to handwashing, access into SCT units and patients rooms, the use of protective clothing for healthcare professionals, and guidelines related to patient hygiene. Conclusion: The surveys have demonstrated that there continues to be a variable approach. Despite the educational interventions performed, this has had a limited impact on the adoption of evidence based practice. One suggestion may be to modify the approach to education in order to ensure a greater diff usion of the educational intervention. In light of the fi ndings, the GITMO Nurses Group plan to develop a position statement regarding protective isolation in order to provide evidence based guidance. Disclosure of Interest: None Declared. Aim: The aim of this study is to describe the process of reporting and handling the adverse eff ects and dangerous situations in our unit. The target of the adverse eff ect reporting is to improve patient care but not to make anyone feel guilty. Method: The stem cell collection and transplantation unit has been JACIE/EBMT accredited since 2006 and the reaccreditation was admitted in 2011. The unit follows EU-regulations and JACIE instructions. The national Finnish Medicines Agency (FIMEA) has licensed the unit according to the Finnish laws and regulations. Currently our unit performs annually 45-55 stem cells collections (autologous + allogeneic sibling donors) and 20-30 autologous and 40-45 allogeneic transplantations. Adverse events have been collected since 2002 both from the collection (apheresis facility is situated at the clinical department) and transplantation sectors (a paper form). An electronic system to report adverse eff ects and dangerous situations is also available. In the electric system it is not allowed to inform e.g. the name of the patient/nurse/doctor who is the target of the report. The unit recommends the personnel to use the paper form, because it allows more information from the event. The paper form includes the following sections: 1) The event date and description.
NP050 THE USE OF PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) IN PATIENTS UNDERGOING HEMATOPOIETIC PROGENITOR CELLS (HPC) TRANSPLANTATION
NP052 ADVERSE EVENTS AND DANGEROUS SITUATIONS IN THE CLINICAL STEM COLLECTION AND TRANSPLANTATION UNIT AT A SINGLE TRANSPLANT CENTRE
2) The estimation why did it occur? 3) How to prevent similar events in the future? 4) A need for a report to authorities (FIMEA)? 5) Does the event induce a change to standard operating procedures (SOP)? 6) The date and the name of the person who made the report. 7) The name of the programme director after checking the report. All the events are discussed four times a year at the quality management (QM) meetings and the sections 3-5 are handled there.
Results: The number of the reports in the collection sector has been from 5 to 16 annually and 10-25 in the clinical transplantation activities. There has never been a deviation causing a need of intensive care or a death. The number of the reports in the collection sector has been 57 deviations since 2004. 30% were linked to the function of collection machine, 14% to the collection sets, 14% to screening samples of infections and 42% were single other events. In the transplantation sector there have been 130 deviations since 2004. 32% had something to do with delivery of medicines, 22% were linked to stem cell infusion and 14% to infection samples. 32% were single events. Conclusion: The aim of adverse event and dangerous situation reporting is to improve patient care and make it safer. In most reported reports the life of the patient has not bee threatened. If the same adverse events repeated or there were a single dangerous event it is import to try to fi nd a solution to the problem and estimate whether e.g. more training is needed. Aim: With the introduction of reduced intensity conditioning regimes in the last 15 years there have been an increasing number of patients undergoing allogeneic stem cell transplant. Post allogeneic transplant can often be the most challenging and diffi cult time for patients and their families due to the prolonged nature of the recovery along with a host of potential complications. Verbal feedback from our patients has been that post transplant they often feel lost and overwhelmed for the challenging and lengthy recovery process. Although they are very closely followed up by the medical team, support with issues such as weight loss, diet, fatigue and the psychological impact of the transplant can be sporadic and inconsistent which has lead us to identify a lack of support.Our aim was to initiate changes within our unit that would address these issues and therefore better support the patients and three initiatives have been identifi ed. Method: Firstly an introduction of a fortnightly multi disciplinary team (MDT) meeting was commenced to discuss pre and post transplant patients and any potential or actual concerns. Prevention or early intervention could then be planned and implemented. Secondly on discharge patients would have a discharge talk from a clinical nurse specialist (CNS) who would then follow them up in clinic. In identifying themselves in this role the patient and their family were then clear on who they should contact if they had any concerns and regular contact could now be achieved in the transplant clinics. Lastly a fortnightly coff ee morning for relatives to meet other relatives going through similar experiences was commenced; we provided information on what is available within the hospital and in their local communities to support the patients and their families. We encouraged sharing experiences and utilising the support off ered both internally and locally. Results: We hope that implementing these changes has improved the patient experience post transplant in identifying patient issues early on. Timely referral to the appropriate team ensures earlier intervention and potentially prevents admission. This then enables patients to manage their symptoms and remain an outpatient, promoting independence. Providing information to families allows them to feel better prepared for caring for their relatives when at home and be better informed on how to access support. Conclusion: Developing this support further is essential if we are to continue to increase the amount of allogeniec transplants that we carry out; however it has had an impact on the workload of the current CNS's. The long term solution could be to have a post transplant CNS whose role was specifi c to working with the post transplant patient and addressing their needs. Disclosure of Interest: None Declared. Aim: Involved for many years in JACIE accreditation, we organized a specifi c formation for nurses in our haematology department. We decided to adapt our program courses to heterogeneous team members (some nurses worked for many years in the BMT unit, others just arrived). Method: Initially, this formation was planned for BMT unit nurses. For two years, we extended the program to auxiliary nurses and colleagues working in other units. We planned 5 diff erent sessions. Rule was to attend the all program in two years. At the beginning of the year, we listed preponderant themes (medical one as haematological emergencies, acute leukaemia and graft, NHL, but also juridical aspect of nurse responsibilities and clinical research practice). In order to reach a large population, we repeated two or three times per year each formation's day. We also set up mixed small groups (nurses, auxiliary nurses with diff erent experience). Each formation day is built as following: -During the morning, medical lecture.
NP054 CONTINUOUS VENO-VENOUS HEMOFILTRATION IN BMT UNIT: THE NURSING CARE
-After lunch, several actual instances drew inspiration from a specifi c history patient. Regular lectures are given by medical doctors or senior executive but participant were invited to ask many questions. In the afternoon, the 20 participants were divided in four multidisciplinary groups and had to resolve one specifi c medical case. After 30 minutes, each group presented his results to the audience. All presentations were then discussed by the group. Results: After two years of experience, we noted very positive aspects:
-Communication improvement between diff erent team members.
-Interactivity/dynamism.
-Doping experience exchanges because of multidisciplinary group composition.
-Strength connection from theoretical to practical knowledge, -At the end of the day, good practices reminder by head nurses. Conclusion: To conclude, this project is probably the fi rst step for institutional plan to create a nursing passport. This document will be built from regular formation (hygiene, pain) to high specifi c teaching as JACIE's experience. Such passport will increase status of nursing staff . Disclosure of Interest: None Declared.
NP056 PROJECT OF SUPERVISION FOR HEMATOLOGY-ONCOLOGY NURSES -FIRST EXPERIENCES M. Zitkova 1,2,* , J. Spackova
Aim: The regular refl ection on nursing care itself, which takes place in a safe, supportive and friendly environment during the supervision, is the best way of improving the quality of the care provided, of developing professional skills and dealing with the problems in a team of professionals in a constructive way. Although, at present, supervision has not been legislatively fi xed in the Czech health care system and nursing yet, as it is the case e.g. in other EU countries, a supervision project focused on hematology-oncology nurses was started in 2012. The project is supported by MH CZ -DRO (FNBr, 65269705) . Method: In the fi rst 18 months, nurses in adaptation process working at a particular clinic were included in this Project. The data were obtained both from the supervisor´s records and from the evaluation questionnaires where the participants in supervision sessions evaluated both the contribution of these sessions and the organization and the course of the whole Project. Results: The supervision program contained 29 professionals, the sample consisted of 100% women at the age between 20 and 23 years. 23 questionnaires were used for subsequent analysis (incompletely fi lled in questionnaires were excluded). In the fi rst 18 months of the Project, 48 supervision group sessions were held in the total range of 62 hours of supervision work with 4 supervision groups. The average duration of one session was 80 minutes. 92% participants attended the sessions. 23.2% respondents mentioned the personal growth as the most important personal contribution of the supervision program, 18.6% respondents perceive the personal contribution in dealing with problems and confl icts at the workplace, 13.9% fi nd the feedback and various views of the situation to be contributive, 11.6% see the contribution in consolidating the team. 6.9% respondents appreciate the development of communication, more information on particular situations and the chance to express their opinions. 4.6% perceive as contributive getting higher knowledge of the workplace and awareness of their own shortcomings. 2.3% cannot see any personal contribution of the program. Conclusion: The introduction of a regular regimen of super vision for nonmedical health care staff , i.e. for nurses, sets the goal of keeping a proper level of staff ´s motivation, support of personal growth, strengthening of professional self-confi dence and meeting their needs with regard to work. The supervision provides nurses with regular refl ection of their own nursing activities. Thanks to the Project, the staff develops communication abilities and skills. Within the fi rst experience, the methodology of implementation of supervision work was set and in the next year, the Project will be focused on its extension and improvement. HSCT, Gaslini Children Hospital, Genoa, 2 HSCT, Gaslini, Genova, 3 HSCT, Gaslini, Genoa, Italy Aim: Background In 2007 , the Gaslini Institute started the accreditation process with Joint Commission International. Among required standards, there were the assessment and satisfaction of patient's educational needs. Nursing team proposed a project of an educational record for HSCT patients. The objective of this project is to give children and their families the opportunity to know the therapeutic process, starting from admission through hospitalization until discharge. In this way, they can share with health care providers the therapeutic choices and acquire the skills they will need when they return back home, including self-confi dence, self-management, and resumption of a satisfying social life. All this can be achieved through an appropriate educational approach, in particular using a educational record. Method: Existing educational material was reviewed. We considered only educational record containing:
Educational diagnosis Educational contract Assessment of skills to be acquired Methods and techniques to be adopted Evaluation of results Our team was divided in four groups working on: CVC management; Oral therapy at Home; Hygienic care; Diet. New educational records was proposed and tried Results: Only few patients have been involved, but some feedback as already been obtained. Most importantly: Greater control of the skills of caregivers; A greater confi dence of patients and their families; Signifi cant increase in the number of questions that parents ask us and therefore in our opportunities for help; The evaluation of their progress make parents more selfconfi dent. Conclusion: Most colleagues have felt involved and collaborated in the experimentation; it is necessary to fi nd dedicated people as reference persons of the educational program. For some colleagues, it is necessary to assess the increase in the workload. This did not happen in our experience. Dedicated space in the existing nursing record is a strong motivation prompting nurse to report the educational acts in writing. Undoubtedly, the patient is better managed at discharge. Disclosure of Interest: None Declared. Aim: In January of 2013 we launched a 16 week educational program focussing on the basic care needs, side eff ects, and nursing interventions required of transplant patients. With increased patient acuity, new transplant treatment modalities and a junior nursing team, it was necessary to ensure all staff had the fundamental knowledge to be able to link theory to practice in transplant nursing. Method: We began by selecting key areas of transplant nursing we deemed important for nurses taking care of such patients. To decide these key areas we discussed what we perceived the most important areas of care based on our patient group and treatment modalities. We concluded that these issues were common side eff ects faced, increasing themes in incident reporting, and the level of knowledge and skill of our nursing staff . With a large nursing complement, one of the challenges faced was how to format the program. We decided that each topic would be taught over the space of 1 week as a dedicated theme, with 3 sessions of 30 minutes taught per week. When dedicating a week to each theme, we were able to expand our teaching approach and utilise methods such as teaching boards, handouts,and multimedia in order to cater toward all types of adult learning styles. One of the most important aims of the program was to ensure standardisation throughout the nursing team. To be able to do this, we made it mandatory that each nurse must attend 1 of the teaching sessions each week and that successful completion of the program would be a key objective of every nurse's yearly performance appraisal and development plan. Results: Upon completion of the program 90% of all nurses completed it successfully. There was a reduction in the amount of transplant related incident reports and 3 submissions for staff to attend post graduate courses specialising in transplant nursing. Based from feedback forms, >95% of the nursing team found the teaching sessions useful and it catered to their learning needs. 100% wanted the program to continue next year. Conclusion: Through the implementation of a formalised training program we were able to provide our nursing team with fundamental transplant education and the tools to be able to link theory to practice. We were able to acknowledge the importance of standardisation across nursing practice and to promote empowerment and confidence within the nursing team to achieve best patient outcomes. Disclosure of Interest: None Declared. Infusional side-eff ects were documented for 1/27 patients who experienced hypotension during the infusion. This was managed by delaying the infusion of the subsequent HPC bag. No other incisional side-eff ects were noted. All HPC products had been checked with two staff members as required by the local SOP. However, there was room for improvement in th completion of the associated documentation. Although the pre-medication administered was documented at 100% of the forms reviewed and the documentation of the observations preand post -infusion was similarly 100%, the documentation was complete in only 10/33 forms. Fields commonly not completed included CD34 dose, type of HPC product and any manipulation required. Conclusion: Infusion of HPC products is a key part of the transplant process and it is vital that the nursing staff carrying out the procedure is competent in the procedure. This audit demonstrated the importance of the ongoing monitoring of clinical practice as although all nurses administering the HPC products were deemed and assessed competent, there was wide variation in practice in both infusion times and documentation. Issues regarding incomplete documentation also raise concerns about the accuracy of the incidence of infusional side-eff ects (1/27 patients). The high number of HPC infusions out of hours ( after 5 pm) should also be investigated further to understand factors that may delay the infusion of HPC products. To date, 9 patients have been treated with clofarabine, with dozens more expected to receive the therapy over the next 4 years. Introduction of the study protocol entailed the issues of proper preparation to the new treatment, including drug information, nursing staff training, patient follow-up and staff cooperation. Our study aimed to determine the tools for strengthening cooperation within the nursing staff ; prevention of treatment errors; improving patient understanding and involvement in the treatment process. Method: Nurses participating in the study were interviewed, with a focus on knowledge about the drug and its side eff ects, availability of administration guidelines, ability to provide information to the patient, extra workload, substantial mental and physical strain, and feeling of being a part of the trial. Analysis of their responses was performed.
NP060 OBSERVATIONS OF CLINICAL PRACTICE: A PROSPECTIVE AUDIT OF HPC INFUSIONS
Results: The interviews showed that the lack of information caused stress and uncertainty in the nursing staff and strengthened their feeling of not being an active part of the study. These factors manifested themselves as a decline in motivation and staff cooperation. Based on the analysis, the nurses were given an overview of the study in general and the drug in particular. A drug administration protocol was developed and documented in the unit computer system. Patient information sheets were prepared and distributed among patients. The unit policy regarding implementation of study protocols was established. No errors were found in provision of the study therapy (in terms of duration and patient follow-up), in contrast to the pre-intervention phase. A new policy for future introduction of clinical study treatments was developed. Conclusion: The current study has demonstrated the importance of detailed instruction of the nursing staff prior to the introduction of study protocols and cooperation of the multi-disciplinary team participating in the study. Aim: To identify adverse reactions presented by multiple sclerosis (MS) and type 1 Diabetes mellitus (T1DM) patients, who underwent immunosuppressive conditioning regimen, including anti-thymocyte globulin (ATG), followed by autologous hematopoietic stem cell transplantation (AHSCT). Method: This is a cross-sectional, observational study with retrospective data collection.
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Results: The trial included 49 MS and 23 T1DM patients. Thirty-three (67%) of the MS patients were females, with mean age of 37.2 years. Twenty-one (42,9%) patients presented the relapsing-remitting form of the disease and the Expanded Disability Status Scale (EDSS) varied from 3.0 to 6.5. With regards to the T1DM patients, 16 (43%) were males, with mean age of 18.26 years. All had positive antibodies against the beta cell pancreatic antigen glutamic acid decarboxylase (antiGAD65). Among the side eff ects manifested by MS patients, we detected predominantly hydric retention and headache, while T1DM patients presented mostly chills, fever, headaches, nausea and vomits. The main nursing interventions towards T1DM and MS patients were vital sign monitoring, hydric control, optimization of anti-emetic administration, control of the ATG infusion rate, nutritional orientation and prevention of trauma. Type 1 DM patients showed higher incidence of acute adverse reactions and longer need of continuous monitoring. MS patients were more dependent of nursing care, demanded more care time by the nursing team. . The consultation starts with patient information, medical care and support during chemotherapy and stem cell mobilization. During the fi rst three months after autoSCT patients are seen at the outpatient clinic by the NP under supervision of a hematologist. Depending on the complications after discharge, a standardized medical history and physical examination is performed by the NP during a 30 minutes visit. One year after autoSCT, distress will be assessed with the help of a validated distress thermometer and problem list. The aim of this study was to determine the feasibility of outpatient autoSCT care by a nurse practitioner. Method: Between October 2011 and October 2013, 41 patients (median age 57 year, range 34-67) received an autoSCT. The indications for autoSCT were multiple myeloma(n=19), relapsed Hodgkin lymphoma (n=5), relapsed diff use large B-cell lymphoma (n=6), mantle cell lymphoma (n=4), T-cell lymphoma(n=4) or other hematologic disease(n=3). The NP gave standardized information about the chemotherapy regime and stem cell mobilization with fi lgrastim. During chemotherapy and stem cell mobilization the NP provided structured medical care and support. The NP gave information about the admission and conditioning with (Rituximab) BEAM (n=20), R-BCNU-Thiotepa (n=1) or Melfalan (n=20) and autologous stem cell transplantation. After discharge, the NP provided structured and standardized care during the fi rst three months after autoSCT. The number of consultations varied from weekly to once a month. In addition to medical history and physical examination, patients were counselled on psychological impact and rehabilitation issues. Patient data were analysed with electronic patient records. Results: After successful stem cell mobilization, 41 patients were admitted for chemotherapy conditioning and stem cell transplantation. Forty patients were discharged between day+11 and day +46 (median: day +16) after autoSCT. One patient died from infection-induced multi organ failure during admission. After discharge, two patients were re-admitted in the fi rst three months for abdominal pain and fever. After discharge no non-relapse mortality was observed in this patient group. Patients had 1-10 (median 4) NP consultations and 0-5 (median <1) telephone consultations in the fi rst three months after autoSCT. Conclusion: Standardized and structured outpatient autoSCT care by a nurse practitioner is feasible and is expected to contribute to safe continuity of care. Results from the distress thermometer and October/2013, in the BMT unit of a teaching hospital, in a city in the state of São Paulo, Brazil. The project was approved by the Eth- Aim: In this paper we want to describe an error that happened in a haematology-oncology-and sct unit one year ago, and also share the lesson learned since. Two paediatric patient arrived to the unit's outpatient clinic in order to have previously scheduled blood transfusions. Due to an error the blood units were mixed and infused to wrong patients. One child got symptoms and it was only after the condition was stabilized when the cause of symptoms was found out. Both patients were followed for new symptoms, but both nothing emerged. The incident was reported further, parents were informed and an enquiry of the incident was made. Immediate change to identifi cation protocol with blood products and cytostatic drug was also made. Method: After changing the identifi cation protocol, a survey was made to the nursing staff . Only 18 out of 58 nurses in the unit responded. All the respondents said they knew the identifi cation protocol; 14 nurses said they make the identifi cation by the protocol always or nearly always. 4 nurses said they don't make the identifi cation if they know the patient. There were also 5 comments stating the same idea about not identifying the well-known patient. More information about the meaning of identifi cation was given. Patient identifi cation bracelet usage started in September 2013 (used else where in the hospital for several years). A follow up questionnaire will be spread out to fi nd out how nurses are using the "patient identifi cation bracelet"; are they following the hospital-protocol. Nurse who made the error has been interviewed to fi nd out direct and long term eff ects to work and overall satisfaction. Support from managers and colleagues is described. Conclusion: Several changes in nursing practice were made as a result of this error. Although we had a well established protocol in place for reporting and handling errors; with this incident we learned to be even more open. In the future we need to keep on discussing about errors openly. We must investigate more closely also less serious errors that we see to have great importance to the daily practice. One error can lead to several changes if it is investigated thoroughly and the follow up is organised. It is also paramount to take care of the individual who made the mistake as well as the patient and family. Results: A total of 223(68.6% response rate) expatriate nurses employed in the Hematology/Oncology units were surveyed.104 (46.6%) of the participants reported intent to leave within the next 1-3 years. Leavers were less satisfi ed in all satisfaction subscales than the stayers. Signifi cant Diff erences were found between marital status and nationalities on one side and intention to leave on the other side (P value= 0.027, 0.014 respectively). Predictors of intent to leave were dissatisfaction with diff erent job aspects. The fi ndings of this study were both parallel with and unalike to the results of previous studies. More than 45% of the participants intended to leave working in the hematology/ oncology area within the coming 3 years. Intention to leave has been found to be related to job satisfaction and nurses' characteristics. Those nurses who intended to leave were less satisfi ed with all job aspects than those who intended to stay. Demographic characteristics of the participants and work conditions were found to be in relation with both job satisfaction and intent to leave on diff erent levels. Conclusion: Study results predict relationships between job satisfaction and intent to leave the work at Hematology/Oncology areas or the organization. Findings can be utilized by nursing managers and policy establishers to enhance job satisfaction and use it as predictor for intent to leave. Aim: Because of the increasing number of patients and their complexity of care there is less time remaining for the ward nurse to consider her own wellbeing? The literature shows that nurses' perception of quality of care and job satisfaction increases when there is a supportive environment and the intention to leave the job decreases. The most important component of any retention strategy is maintaining a work environment that supports and respects professional nursing practice. But how do we keep our hematology nurses happy? Aim: In the hematology/oncology ward, there was a general feeling of shortage in communication or miscommunication. Furthermore, 'teamwork' was felt to be absent and aff ected how staff members felt about teambuilding, collaboration, self-employment and job satisfaction. The question was raised how can we better support our nursing staff and invest time in developing and maintaining the team cohesion. Method: 1. Team meetings were re-introduced in a schedule of every two months. During these meetings the aim was to hear the opinion of the nurses about communication and collaboration among the team and make a plan together about how we will proceed. Interventions to improve the collaboration were developed and implemented. The aim being to make the team more involved and valued and hears the nurses' perception on quality of care in our ward. 2. A self administered survey was developed based upon the fi ndings of a literature search on factors that can infl uence job satisfaction among nurses. In twenty questions using a 5-point likert scale opinions were asked about the above subjects Results: 1. The re-introduction of team meetings was evaluated. The nurses indicated that the communication in the team is getting better and the interventions that came out of the meetings are successful. 2. From the 31 questionnaires sent out, 27 (87.1%) were returned. Sixty fi ve percent of the nurses are very satisfi ed with their job and 23% are reasonably satisfi ed. When asked about support from the ward for the nurses' well-being, 54% say there is enough support. The nurses are reasonably satisfi ed (58%) with the level of communication, and regarding collaboration the nurses say it is reasonably good (54%). The intention to leave the department is low. Conclusion: These fi ndings show that the nurses are satisfi ed and have no intention to leave the department. Our evidence suggests that our nurses are reasonably satisfi ed with the communication but they experience work related stress fairly often. In the literature we can fi nd that stress and teamwork are two important factors in the decrease of job satisfaction. These fi ndings indicate that although the nurses are satisfi ed with the support that is given, there is still room for improvement in the areas of communication and work related stress. The department wants to progress from a team of staff that are reasonably satisfi ed to staff that are satisfi ed or even more than satisfi ed. This communication's objective is to highlight how important the continuation of the educational process, which has been interrupted by the development of the disease, is. The Hospital Teaching Unit (HTU) tries to give as much normality as possible during their stay at the Hospital, making sure that the child could be "student" instead of patient, for a few hours. In a collaborative work nurses, physicians, and teachers have developed tools in order to make daily care routines (like washing mouths, taking shower, physiotherapy, eating, respiratory physiotherapy and much more) easier and more enjoyable.
In addition "the touching screen", is a new technological tool which allows us to approach the children to their day by day school routines and breaks the isolation due to the hospital stay and at the same time is an educative and cheerful tool. Conclusion: New "screen" is a therapeutically tool that allows the educational process to continue and to prevent school gap as well as to keep the link with the school and friends as the main objectives. Parents, children and teachers' assessment should be made in order to let then know about the usefulness degree of the new tool. Disclosure of Interest: None Declared. Aim: From autumn 2010 to the beginning of the year 2012 Helsinki University Hospital´s Pediatric cancer, hematology and stem cell transplant unit organized in collaboration with a local University of Applied Sciences, Arcada, a specialization course for nurses. This was the third course that was kept within 10 years. The participants for the course was chosen according the amount of experience on the pediatric cancer ward. Nurses that were now chosen had been working on our ward for a minimum of 5 years. For getting the most out of a this kind of a advanced course one has to have possessed a certain basic knowledge of cancer treatments and diagnoses. There were two main goals for the course, fi rst to increase the know-how in our work and for second to develop something new and useful for fulfi lling the entire work communities needs.
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Method: The course included 3 diff erent learning entities, all together 30 learning credit points (1 point = 27 hours of work). First big entity was general studies (5 points) including orientation for studies, instructions for making a poster and well being at work and development of work community. Second entity was basic studies (19 points), lectured by physicians and experienced nurses from our ward. This entity included advanced knowledge of malignancies, stem cell transplants and GVHD, late eff ects of cancer treatments, infections (viral, fungal and bacterial), pain treatment and end of life care. The last but not least entity was advanced studies (6 points) which meaning was to produce something new and useful for all our word. The development works had two parts; evidence based theory part and a product for general use. Results: The participants on the course developed fi ve products for the wards use. We got a new PCA-pump instruction sheet for nurses. Information fi les for families (our daily routines, maps, contact information´s for our special workers ect). An information sheet for families about our own anesthesia unit and the operations done there. An information sheet about notable things in work safety for pregnant nurses on a cancer ward and a care plan for patients undergoing a collection of peripheral blood stem cells. Conclusion: The course gave for the participants a lot of new knowledge and tools for everyday work on the ward. The development products have been in active use on the ward and they have been useful tools for instructing both families and staff . This kind of advanced courses benefi ts the whole work community. The invested money and time returns to the work community´s use as an increased know-how and enthusiasm for work. Disclosure of Interest: None Declared. Aim: Introduction: Bone marrow transplant in children is one of the most dramatic treatments in the modern medical world. Many children, suff ering from oncologic and/or metabolic diseases, denied a cure by conventional care, have recovered well, thanks to this treatment. The preparatory treatment for a transplant includes chemotherapy in high doses, often in conjunction with radiation therapy. Children and their families are full participants in the entire process, from the moment of decision-making for the need of treatment, to the actual transplant, and on to the recovery stage. Patients and Methods: We have prepared an explanatory fi lm called "Transplant for Life" to help answer many of their questions and to help them cope with the transplant procedure. The training fi lm is for both autologous and allogenic bone marrow transplants. It describes the process of the transplant, beginning with the admission of the child for transplant, the preparatory exams, the cell collection process, preparatory chemotherapy treatment, transfusion of the cells, and tolerance of the transplant, recovery, and preparation for discharge from hospital. The idea of producing a training movie arose from the desire to help children to understand what they will be going through, using concepts familiar to them. This type of movie allows children to see this experience from close up, thus allowing the children and their families, parents as well as siblings, to better understand the process of what the child will be going through. It is designed to reduce the child's fears and anxieties, and to show him/her what to expect. Conclusion: We hope that this fi lm will prove to be a useful and helpful tool for patients and their families, as well as a source of guidance for the teams and students providing their care. Families whose children are about to undergo transplants and the medical team showed a high level of satisfaction with the educational aspects of the fi lm, and were excited about participating in this project. Disclosure of Interest: None Declared.
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